Mon, Dec 29, 2014, 11:59 AM EST - U.S. Markets close in 4 hrs 1 mins


% | $
Quotes you view appear here for quick access.

Medivation, Inc. (MDVN) Message Board

  • berkelygenie berkelygenie Jan 23, 2013 1:53 PM Flag

    Why MDVN is worth $6 a share.

    First it missed the boat by greedy pricing 40% more than Zytiga. Most drug plans won't cover it so it will follow DNDN from $45 to $6.. Second, it didn't invent Xtandi. Its original inventor already had a better drug, ARN509 will be soon approved and MDVN lost the patent rights to it. ARN509 has no siezures, fewer side effects and is more effective. MDVN only owns half of one drug and 10% of its profits from Xtandi go to UCLA. Market cap of Xtandi should be $1 Billion but it is currently $10 Billion based on MDVN's price.

101.24-1.05(-1.03%)11:59 AMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.